Magenta Therapeutics is a biotechnology company harnessing the power of stem cell science to revolutionize stem cell transplantation for patients with immune- and blood-based diseases. By creating a platform focused on key areas of transplant medicine, Magenta Therapeutics is pioneering an integrated, but modular approach to stem cell therapies that reboot the blood and immune systems to create patient benefit. Founded by internationally recognized leaders in stem cell transplant medicine, Magenta Therapeutics was launched in 2016 by Third Rock Ventures and Atlas Venture and is headquartered in Cambridge, Mass.

- Thought partner to Global Brand Teams and MS commercial franchise to prioritize and answer key business questions via custom analytics and intuitive models- Delivered US and EU brand and portfolio narratives in collaboration across geographies and functions, integrating primary and secondary data into consensus insights- Led patient volume long range planning and business development activities in MS, working across brands, finance, market research, competitive intelligence, and market access- Led capabilities building in advanced and predictive analyticsTherapeutic Area Expertise: MSAssociate Director: Jun 2016 - Dec 2016Senior Manager: Apr 2015 - Jun 2016

- Led case teams of 3-5 members in strategy consulting projects for pharma and biotech clients- Experienced with disease/indication prioritization, therapeutic area strategies, opportunity assessment, product launch strategy and tactical planning (Commercial and Medical), market development, brand planning, sales force effectiveness, due diligence, business development- Led multiple internal firm initiatives, including Recruiting and TrainingTherapeutic Area Expertise: rare diseases (in particular, neurodegeneration and neuromuscular), ophthalmology (retinal and corneal), oncology, immunology, painManager: Jul 2014 - Apr 2015Consultant: Jul 2012 - Jun 2014Associate: Sep 2011 - Jun 2012